Prosecution Insights
Last updated: April 19, 2026

Sanofi Pasteur Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
4
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17802758 HIGH DOSE FLU VACCINE IN PEDIATRIC SUBJECTS BARRERA, IMMACULADA 1671 Final Rejection Aug 26, 2022
17843445 MULTIVALENT INFLUENZA VACCINES HILL, MYRON G 1671 Final Rejection Jun 17, 2022
17606614 DOSAGE REGIMENS FOR AND COMPOSITIONS INCLUDING ANTI-RSV ANTIBODIES BUCKMASTER, MARLENE VRENI 1672 Final Rejection Oct 26, 2021
17280377 COMBINED IMMUNIZATION AGAINST MENINGOCOCCAL DISEASE AND HUMAN PAPILLOMAVIRUS GILL, RACHEL B 1671 Final Rejection Mar 26, 2021

Managing Sanofi Pasteur Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month